These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35646140)

  • 1. Chromobox Homologue 7 Acts as a Tumor Suppressor in Both Lung Adenocarcinoma and Lung Squamous Cell Carcinoma via Inhibiting ERK/MAPK Signaling Pathway.
    Huang J; Zhang W; Lin D; Lian L; Hong W; Xu Z
    Evid Based Complement Alternat Med; 2022; 2022():4952185. PubMed ID: 35646140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
    Yang Y; Hu Z; Sun H; Yu Q; Yang L; Yin F; Sun Y; Pu L; Zhu X; Li S; Chen X; Zhao Y
    Onco Targets Ther; 2021; 14():5477-5492. PubMed ID: 34992383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.
    Zhang LX; Gao J; Long X; Zhang PF; Yang X; Zhu SQ; Pei X; Qiu BQ; Chen SW; Lu F; Lin K; Xu JJ; Wu YB
    Mol Cancer; 2022 May; 21(1):110. PubMed ID: 35525959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway.
    Niu N; Ma X; Liu H; Zhao J; Lu C; Yang F; Qi W
    Exp Lung Res; 2021; 47(4):173-182. PubMed ID: 33678109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.
    Zhao W; Liu L; Li X; Xu S
    Int Immunopharmacol; 2022 Sep; 110():109031. PubMed ID: 35839564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
    Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
    Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
    Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
    Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.
    Cheng J; Xia L; Hao X; Gan F; Bai Y; Zhang C; Mao Y; Zhu Y; Pu Q; Park DW; Tavolari S; Mei J; Chen Y; Deng S; Liu L
    Transl Lung Cancer Res; 2022 Jun; 11(6):1089-1107. PubMed ID: 35832442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
    Ma X; Yang S; Jiang H; Wang Y; Xiang Z
    J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway.
    Yu XY; Wang M; Qian JJ
    Evid Based Complement Alternat Med; 2022; 2022():2501846. PubMed ID: 36159575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathway.
    Zhou Y; Zhao Y; Ma W; Zhang L; Jiang Y; Dong W
    Discov Oncol; 2022 Dec; 13(1):136. PubMed ID: 36482116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
    Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
    BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.